Update to the AHA/ASA Recommendations for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack
Robert J. Adams(American Heart Association), Lee H. Schwamm(Yale University), Karen L. Furie, Philip B. Gorelick(American Heart Association), Gregory W. Albers(Stanford University), Robert E. Harbaugh(Pennsylvania State University), Irene Katzan(American Heart Association), Mark J. Alberts(Nanotherapeutics (United States)), Michael Marks(American Heart Association), Oscar Benavente(University of British Columbia), Margaret Kelly‐Hayes(American Heart Association), Larry B. Goldstein(American Heart Association), Jonathan L. Halperin(Greenville College), S. Claiborne Johnston(University of Nottingham), Ralph L. Sacco(American Heart Association), Edgar J. Kenton(American Heart Association)
Cited by 480
Related Papers
Rivaroxaban versus Warfarin in Nonvalvular Atrial Fibrillation
|New England Journal of Medicine|2011|9.4k
Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration
|The Lancet Neurology|2013|5.4k
Guidelines for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack
|Stroke|2014|5.2k
Stent-Retriever Thrombectomy after Intravenous t-PA vs. t-PA Alone in Stroke
|New England Journal of Medicine|2015|5.1k